Your browser doesn't support javascript.
loading
Polyphenol-based nanoplatform for MRI/PET dual-modality imaging guided effective combination chemotherapy.
Wang, Jingjing; Sang, Wei; Yang, Zhen; Shen, Zheyu; Wang, Zhantong; Jacobson, Orit; Chen, Yundai; Wang, Yong; Shao, Mingyan; Niu, Gang; Dai, Yunlu; Chen, Xiaoyuan.
Afiliação
  • Wang J; Department of Cardiology, Chinese PLA General Hospital, Beijing 100853, China and Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA. shawn.chen@nih.gov.
  • Sang W; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR 999078, China. yldai@um.edu.mo and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR 999078, China.
  • Yang Z; Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA. shawn.chen@nih.gov.
  • Shen Z; Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA. shawn.chen@nih.gov.
  • Wang Z; Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA. shawn.chen@nih.gov.
  • Jacobson O; Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA. shawn.chen@nih.gov.
  • Chen Y; Department of Cardiology, Chinese PLA General Hospital, Beijing 100853, China.
  • Wang Y; School of Life Science, Beijing University of Chinese Medicine, Beijing 100029, China.
  • Shao M; School of Life Science, Beijing University of Chinese Medicine, Beijing 100029, China.
  • Niu G; Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA. shawn.chen@nih.gov.
  • Dai Y; Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR 999078, China. yldai@um.edu.mo and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau SAR 999078, China.
  • Chen X; Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892, USA. shawn.chen@nih.gov.
J Mater Chem B ; 7(37): 5688-5694, 2019 10 07.
Article em En | MEDLINE | ID: mdl-31475276
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Nanopartículas / Neoplasias Limite: Humans Idioma: En Revista: J Mater Chem B Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Nanopartículas / Neoplasias Limite: Humans Idioma: En Revista: J Mater Chem B Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido